abstract |
The present invention relates to novel spiro-piperidine derivatives as V1a receptor antagonists, their preparation, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful for the prevention and / or treatment of anxiety and depressive disorders and other diseases. The compounds of the present invention are described by the general formula (I) (wherein R 1 to R 5 , R 5 ′ , R 7 to R 9 , R 7 ′ , R 8 ′ , X and Y are As defined in). |